Nordic Capital Invests in eResearch Technology,Inc.

We represented Nordic Capital Fund VIII (Nordic Capital) as special healthcare counsel in its definitive agreement to become the new controlling shareholder of U.S. – based company eResearch Technology, Inc. (ERT). Terms of the transaction were not disclosed.

Nordic Capital Funds invest in companies in northern Europe and in selected investment opportunities internationally. Nordic Capital Fund VIII has EUR 3.5 billion in committed capital, principally provided by international institutional investors such as pension funds. ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development.

You Also May Be Interested In:

  • Representation of AutoZone, Inc. (NYSE: AZO) in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000% Senior Notes due 2030

    We represented AutoZone, Inc. in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000%...
    Client Type: Public Company
  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Client Type: Private Company